Development of gliclazide matrix tablets from pure and blended mixture of glyceryl monostearate and stearic acid by Hussain, Talib et al.
1475ISSN 0326-2383
KEY WORDS: Gliclazide, Glyceryl monostearate, Matrix tablets, Stearic acid, Sustained-release.
* Author to whom correspondence should be addressed. E-mail: mna19bwp@yahoo.com
Latin American Journal of Pharmacy
(formerly Acta Farmacéutica Bonaerense)
Lat. Am. J. Pharm. 30 (8): 1475-80 (2011)
Regular Article
Received: April 26, 2011
Revised version: June 3, 2011
Accepted: June 8, 2011
Development of Gliclazide Matrix Tablets from Pure
and Blended Mixture of Glyceryl Monostearate and Stearic Acid
Talib HUSSAIN 1, Tariq SAEED 1, Ahmed M. MUMTAZ 1, Muhammad JAMSHAID 2,
Muhammad N. AAMIR 3*, Khizar ABBAS 1,  Zeshan JAVAID 4 & Azeema AWAIS 5
1 University College of Pharmacy, University of the Punjab, Lahore, Pakistan
2 Faculty of Pharmacy, Hajvery University, Lahore, Pakistan
3 Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore, Pakistan
4 Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Pakistan
5 Bahauddin Zakariya University, Multan, Pakistan
SUMMARY. The present study was undertaken to evaluate the effect of glyceryl monostearate (GMS) and
stearic acid (SA) on the release profile of gliclazide from the matrix. Matrix tablets for the controlled de-
livery of gliclazide were prepared by hot melt method using pure and blended mixture of glyceryl monos-
tearate and stearic acid in different drug to polymer and polymer to polymer ratios. In vitro release char-
acteristics of gliclazide from these hydrophobic matrices were studied over 8 h in phosphate buffer media
of pH 7.4. The release kinetics of drug was evaluated for zero order, first order, Higuchi and Peppas kinet-
ic models. It was observed that the release of drug from the matrix was greatly retarded by GMS and re-
tarding effect increased with increasing polymer to drug ratios. On the other hand SA appeared to chan-
nel the drug from the wax matrix and release was greatly increased with increasing polymer to drug ra-
tios. The kinetic evaluation of release profile indicated that the Higuchi model was the most appropriate
model for describing the release profile of gliclazide. The application of Peppas biexponential equation in-
dicated that non-Fickian release was the predominant mechanism of drug release. The FTIR results
showed no interaction between the drug and the polymers and DSC results indicated that both the drug
and polymers are in amorphous state and no significant complexes were formed. The results indicated that
proper selection of drug to polymer and polymer to polymer ratios were important in order to achieve the
desired dissolution profile in these matrix tablets.
